BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25122196)

  • 1. Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.
    Björner S; Fitzpatrick PA; Li Y; Allred C; Howell A; Ringberg A; Olsson H; Miller CJ; Axelson H; Landberg G
    PLoS One; 2014; 9(8):e105099. PubMed ID: 25122196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?
    Recavarren RA; Chivukula M; Carter G; Dabbs DJ
    Int J Clin Exp Pathol; 2009 Oct; 3(1):87-97. PubMed ID: 19918332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblasts direct differentiation of human breast epithelial progenitors.
    Morsing M; Kim J; Villadsen R; Goldhammer N; Jafari A; Kassem M; Petersen OW; Rønnov-Jessen L
    Breast Cancer Res; 2020 Sep; 22(1):102. PubMed ID: 32993755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer.
    Lee S; Mohsin SK; Mao S; Hilsenbeck SG; Medina D; Allred DC
    Breast Cancer Res; 2006; 8(1):R6. PubMed ID: 16417654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of gene expression in the development of early hyperplastic precursors of breast cancer.
    Lee S; Medina D; Tsimelzon A; Mohsin SK; Mao S; Wu Y; Allred DC
    Am J Pathol; 2007 Jul; 171(1):252-62. PubMed ID: 17591970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
    Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
    BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.
    Abdel-Fatah TM; Powe DG; Hodi Z; Reis-Filho JS; Lee AH; Ellis IO
    Am J Surg Pathol; 2008 Apr; 32(4):513-23. PubMed ID: 18223478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiation.
    Westbury CB; Reis-Filho JS; Dexter T; Mahler-Araujo B; Fenwick K; Iravani M; Grigoriadis A; Parry S; Robertson D; Mackay A; Ashworth A; Yarnold JR; Isacke CM
    J Pathol; 2009 Sep; 219(1):131-40. PubMed ID: 19562735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?
    Turashvili G; Hayes M; Gilks B; Watson P; Aparicio S
    Virchows Arch; 2008 Jun; 452(6):589-98. PubMed ID: 18437416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
    Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
    Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression.
    Bullock MD; Pickard KM; Nielsen BS; Sayan AE; Jenei V; Mellone M; Mitter R; Primrose JN; Thomas GJ; Packham GK; Mirnezami AH
    Cell Death Dis; 2013 Jun; 4(6):e684. PubMed ID: 23788041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis.
    Smith L; Baxter EW; Chambers PA; Green CA; Hanby AM; Hughes TA; Nash CE; Millican-Slater RA; Stead LF; Verghese ET; Speirs V
    PLoS One; 2015; 10(10):e0139698. PubMed ID: 26437339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.
    Shibahara Y; Miki Y; Onodera Y; Hata S; Chan MS; Yiu CC; Loo TY; Nakamura Y; Akahira J; Ishida T; Abe K; Hirakawa H; Chow LW; Suzuki T; Ouchi N; Sasano H
    J Pathol; 2012 Jul; 227(3):357-66. PubMed ID: 22407818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Columnar cell lesions of the breast.
    Schnitt SJ; Vincent-Salomon A
    Adv Anat Pathol; 2003 May; 10(3):113-24. PubMed ID: 12717115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification.
    de Boer M; Verschuur-Maes AHJ; Buerger H; Moelans CB; Steenkamer M; Savola S; van Diest PJ
    Mod Pathol; 2018 Dec; 31(12):1816-1833. PubMed ID: 29976944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
    Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 and p95HER2 differentially regulate miRNA expression in MCF-7 breast cancer cells and downregulate MYB proteins through miR-221/222 and miR-503.
    Gorbatenko A; Søkilde R; Sorensen EE; Newie I; Persson H; Morancho B; Arribas J; Litman T; Rovira C; Pedersen SF
    Sci Rep; 2019 Mar; 9(1):3352. PubMed ID: 30833639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
    Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
    Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.